These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26432177)

  • 1. [Facial palsy sequel and botulinum toxin].
    Benichou L; Labbe D; Le Louarn C; Guerreschi P
    Ann Chir Plast Esthet; 2015 Oct; 60(5):377-92. PubMed ID: 26432177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Buccinator muscle: A new target for botulinum toxin injections in the treatment of facial paralysis sequelae].
    Lacroix G; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2022 Jun; 67(3):125-132. PubMed ID: 35662477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UNILATERAL FRONTALIS MUSCLE PARALYSIS: MANAGEMENT WITH BOTULINUM TOXIN A (CASE REPORTS).
    Goldman A; Wollina U
    Georgian Med News; 2018 Feb; (Issue):73-77. PubMed ID: 29578428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
    Winterhoff J; Laskawi R
    HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of botulinum toxin a in the establishment of symmetry in pediatric paralysis of the lower lip.
    Haykal S; Arad E; Bagher S; Lai C; Hohman M; Hadlock T; Zuker RM; Borschel GH
    JAMA Facial Plast Surg; 2015; 17(3):174-8. PubMed ID: 25742503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: Repartition and kinetics of doses used.
    Risoud M; Aljudaibi N; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2016 Feb; 61(1):10-5. PubMed ID: 25953657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in the management of facial paralysis.
    Cabin JA; Massry GG; Azizzadeh B
    Curr Opin Otolaryngol Head Neck Surg; 2015 Aug; 23(4):272-80. PubMed ID: 26101876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment for facial palsy: A systematic review.
    Cooper L; Lui M; Nduka C
    J Plast Reconstr Aesthet Surg; 2017 Jun; 70(6):833-841. PubMed ID: 28389084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous cooling to manage botulinum toxin injection-associated pain in patients with facial palsy: A randomised controlled trial.
    Pucks N; Thomas A; Hallam MJ; Venables V; Neville C; Nduka C
    J Plast Reconstr Aesthet Surg; 2015 Dec; 68(12):1701-5. PubMed ID: 26385134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced functional oculofacial indications of botulinum toxin.
    Lee C; Kikkawa DO; Pasco NY; Granet DB
    Int Ophthalmol Clin; 2005; 45(3):77-91. PubMed ID: 15970767
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
    Chundury RV; Perry JD
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):70. PubMed ID: 26735958
    [No Abstract]   [Full Text] [Related]  

  • 16. IncobotulinumtoxinA treatment of facial nerve palsy after neurosurgery.
    Akulov MA; Orlova OR; Orlova AS; Usachev DJ; Shimansky VN; Tanjashin SV; Khatkova SE; Yunosha-Shanyavskaya AV
    J Neurol Sci; 2017 Oct; 381():130-134. PubMed ID: 28991664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
    Lucarelli MJ; Wei LA; Diels J
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):70-1. PubMed ID: 26735959
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum Toxin in Facial Reanimation: Map of the Facial Musculature and Dosage.
    VandeWater T; Hetzler L
    Atlas Oral Maxillofac Surg Clin North Am; 2023 Mar; 31(1):71-83. PubMed ID: 36754509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin and facial palsy. Our experience].
    Navarrete Alvaro ML; Junyent J; Torrent L
    Acta Otorrinolaringol Esp; 2010; 61(4):277-81. PubMed ID: 20400055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
    Wei LA; Diels J; Lucarelli MJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.